180 Life Sciences Beta
Qual é o Beta de 180 Life Sciences?
O Beta de 180 Life Sciences Corp. é 0.35
Qual é a definição de Beta?
BETA indica se uma ação é mais ou menos volátil do que o mercado como um todo. Um beta menor que 1 indica que o estoque é menos volátil do que o mercado, enquanto um beta maior que 1 indica que o estoque é mais volátil. A volatilidade é medida como a flutuação do preço em torno da média.
Beta is a measure of the risk arising from exposure to general market movements as opposed to idiosyncratic factors. The market portfolio of all investable assets has a beta of exactly 1. A beta below 1 can indicate either an investment with lower volatility than the market, or a volatile investment whose price movements are not highly correlated with the market. A beta greater than one generally means that the asset both is volatile and tends to move up and down with the market. Beta is important because it measures the risk of an investment that cannot be reduced by diversification. It does not measure the risk of an investment held on a stand-alone basis, but the amount of risk the investment adds to an already-diversified portfolio. In the capital asset pricing model, beta risk is the only kind of risk for which investors should receive an expected return higher than the risk-free rate of interest.
Beta de empresas na Setor Health Care em NASDAQ em comparação com 180 Life Sciences
O que 180 Life Sciences faz?
180 Life Sciences Corp., a clinical-stage biotechnology company, engages in the development of novel drugs for unmet medical needs in chronic pain, inflammation, inflammatory diseases, and fibrosis. Its product development platforms in Phase IIb/III clinical trials include Fibrosis and anti-tumour necrosis factor (Anti-TNF) platform, which focuses on fibrosis and Anti-TNF; Synthetic Cannabidiol (CBD) Analogs platform, which are man-made derivatives of CBD; and a7nAChR platform, which focuses on alpha 7 nicotinic acetylcholine receptor. The company was incorporated in 2016 and is headquartered in Palo Alto, California.
Empresas com beta semelhantes a 180 Life Sciences
- Goldlion tem Beta de 0.35
- AEON Credit Service (Asia) tem Beta de 0.35
- Invitrocue tem Beta de 0.35
- Marsh & McLennan Cos tem Beta de 0.35
- Enzo Biochem tem Beta de 0.35
- North European Oil Royalty Trust tem Beta de 0.35
- 180 Life Sciences tem Beta de 0.35
- Huanxi Media tem Beta de 0.35
- China ITS () Co tem Beta de 0.35
- United Utilities Plc tem Beta de 0.35
- Ameriserv Inc tem Beta de 0.35
- American Equity Investment Life Co tem Beta de 0.35
- Peoples Bancorp Of North Carolina Inc tem Beta de 0.35